 The study is a sub-study of RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain. The treatment will consist of permanent implant of a Precision SpectraTM SCS IPG with either a 32 contact CoverEdgeTM Surgical Lead or with more than 2 percutaneous leads after a successful trial. Programming features and lead options of the Precision SpectraTM SCS System will be evaluated up to 3 months post-IPG activation. Following completion of the 3 month visit, subjects will continue to be followed for up to 36 months per the study requirements of the RELIEF Registry. 